Mmastodon BusinessFinance first seen 12 h ago, last 8 h ago, peak #3
CD&R and McKesson to Buy At-Home Infusion Provider for $5.8 Billion
Original: CD&R, McKesson to Acquire At-Home Infusion Therapy Provider for $5.8 Billion https://www.wsj.com/business/deals/cd-r-mck
Private equity firm Clayton, Dubilier & Rice and healthcare distributor McKesson have agreed to acquire an at-home infusion therapy provider in a deal valued at $5.8 billion, according to the Wall Street Journal. The acquisition highlights continued investor interest in home-based healthcare services, a fast-growing segment as more patients receive intravenous treatments outside hospitals.
Why now: Major healthcare M&A activity, with a $5.8 billion deal signaling investor confidence in home-based medical care.
Evidence
- CD&R, McKesson to Acquire At-Home Infusion Therapy Provider for $5.8 Billion https://www.wsj.com/business/deals/cd-r-mckesson-to-acquire-at-home-infusion-therapy-provider-for-5-8-billion-1beddf40?mod=rss_markets_main # Finance # Business # Healthcare · wsj_markets@robot.villas · 4
API: https://socialmediatrends-api.osmike.com/v1/trends/1256692